Literature DB >> 16369808

Tissue-type plasminogen activator activity in morphologically normal tissues adjacent to gastrointestinal carcinomas is associated with the degree of tumor progression.

Gabriel Scicolone1, Viviana Sanchez, Liliana Vauthay, Federico Fuentes, Alejandro Scicolone, Lorenzo Scicolone, Melina Rapacioli, Vladimir Flores.   

Abstract

PURPOSE: To investigate whether the level of plasminogen activator (PA) activity assayed in gastrointestinal carcinomas and the "morphologically normal tissues" adjacent to them is associated with the degree of tumor progression.
METHODS: Tumor and "normal tissues" were obtained from gastrointestinal surgical samples to assess urokinase-type (u-PA) and tissue-type plasminogen activator (t-PA) activities by radial caseinolytic assay and the expression of PA inhibitor-1 (PAI-1) by ELISA. We compared the PA system between the tumor and "normal tissues" and we investigated the existence of correlations between: (a) PA production in the tumor and "normal tissues", (b) different components of the PA system, and (c) PA system and the degree of tumor progression.
RESULTS: (1) Total PA activity, u-PA activity and PAI-1 expression are significantly higher in tumor than in "normal tissues", whereas t-PA activity does not differ between them. (2) Total PA activity mainly correlates with u-PA activity in tumor tissues and similarly with u-PA and t-PA activities in "normal tissues". (3) There is a significant association between t-PA activity in tumor and "normal tissues" and the degree of tumor progression.
CONCLUSIONS: "Morphologically normal tissues" adjacent to carcinomas present abnormal t-PA activity that is associated with the degree of tumor progression. Assaying of this activity could be useful as a predictive parameter.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16369808     DOI: 10.1007/s00432-005-0066-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  48 in total

1.  Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL-6 while increasing PAI-1, in human OA synovial fibroblasts.

Authors:  J P Pelletier; F Mineau; J Fernandes; K Kiansa; P Ranger; J Martel-Pelletier
Journal:  Clin Exp Rheumatol       Date:  1997 Jul-Aug       Impact factor: 4.473

2.  Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells.

Authors:  Guoping Li; Tian Yang; Jun Yan
Journal:  Biochem Biophys Res Commun       Date:  2002-12-20       Impact factor: 3.575

Review 3.  The plasminogen activation system in tumor growth, invasion, and metastasis.

Authors:  P A Andreasen; R Egelund; H H Petersen
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

4.  Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.

Authors:  S Ganesh; C F Sier; G Griffioen; H J Vloedgraven; A de Boer; K Welvaart; C J van de Velde; J H van Krieken; J H Verheijen; C B Lamers
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

5.  Leading-edge myofibroblasts in human colon cancer express plasminogen activator inhibitor-1.

Authors:  Martin Illemann; Ulla Hansen; Hans Jørgen Nielsen; Peter A Andreasen; Gunilla Høyer-Hansen; Leif R Lund; Keld Danø; Boye Schnack Nielsen
Journal:  Am J Clin Pathol       Date:  2004-08       Impact factor: 2.493

6.  Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.

Authors:  David H Berger; Christine A O'Mahony; Hongmiao Sheng; Jinyi Shao; Daniel Albo; Raymond N DuBois; R Daniel Beauchamp
Journal:  Surgery       Date:  2003-05       Impact factor: 3.982

7.  Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.

Authors:  M M Skelly; A Troy; M J Duffy; H E Mulcahy; C Duggan; T G Connell; D P O'Donoghue; K Sheahan
Journal:  Clin Cancer Res       Date:  1997-10       Impact factor: 12.531

8.  The MET oncogene drives a genetic programme linking cancer to haemostasis.

Authors:  Carla Boccaccio; Gabriella Sabatino; Enzo Medico; Flavia Girolami; Antonia Follenzi; Gigliola Reato; Antonino Sottile; Luigi Naldini; Paolo M Comoglio
Journal:  Nature       Date:  2005-03-17       Impact factor: 49.962

9.  Tissue-type plasminogen activator (tPA) content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance.

Authors:  P Raigoso; A Junco; A Andicoechea; A Gonzalez; J L García-Muñiz; M T Allende; M García-Morán; F Vizoso
Journal:  Int J Biol Markers       Date:  2000 Jan-Mar       Impact factor: 3.248

10.  Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.

Authors:  S Ganesh; C F Sier; M M Heerding; J H van Krieken; G Griffioen; K Welvaart; C J van de Velde; J H Verheijen; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.